Roy Winston, Chief Medical Officer at Pacira BioSciences, Inc. (PCRX), sold 31,254 shares at $61.37 ($1.9M) on 2022-06-06, disclosed to the SEC on 2022-06-08.
Seasonal sale ($1.9M) by Chief Medical Officer — this insider has traded PCRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.55 | 3,533 | $214K | 11.2% |
| 2 | $60.55 | 3,533 | $214K | 11.2% |
| 3 | $60.55 | 2,535 | $153K | 8.0% |
| 4 | $60.55 | 2,535 | $153K | 8.0% |
| 5 | $61.37 | 2,099 | $129K | 6.7% |
| 6 | $61.37 | 2,099 |
| $129K |
| 6.7% |
| 7 | $61.59 | 3,650 | $225K | 11.7% |
| 8 | $61.59 | 2,300 | $142K | 7.4% |
| 9 | $61.59 | 3,650 | $225K | 11.7% |
| 10 | $62.43 | 1,300 | $81K | 4.2% |
| 11 | $62.48 | 1,891 | $118K | 6.2% |
| 12 | $62.48 | 1,891 | $118K | 6.2% |
| 13 | $63.40 | 115 | $7K | 0.4% |
| 14 | $63.69 | 123 | $8K | 0.4% |
| Total | $61.31 avg | 31,254 | $1.9M | 100% |
| Filing → |
| PCRX | SELL | 2022-08-05 | $27K | — | Filing → |
| PCRX | SELL | 2021-06-08 | $278K | — | Filing → |
| PCRX | SELL | 2021-04-02 | $3.1M | — | Filing → |